RIGHT-VENTRICULAR DYSFUNCTION - AN INDEPENDENT PREDICTOR OF ADVERSE OUTCOME IN PATIENTS WITH MYOCARDITIS

被引:125
作者
MENDES, LA
DEC, GW
PICARD, MH
PALACIOS, IF
NEWELL, J
DAVIDOFF, R
机构
[1] BOSTON UNIV MED CTR HOSP,EVANS MEM DEPT CLIN RES,BOSTON,MA 02118
[2] BOSTON UNIV MED CTR HOSP,DEPT MED,DIV CARDIOL,BOSTON,MA 02118
[3] MASSACHUSETTS GEN HOSP,CARDIAC UNIT,BOSTON,MA
关键词
D O I
10.1016/0002-8703(94)90483-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To assess the predictive value of right ventricular systolic function in patients with active myocarditis, the echocardiograms of 23 patients with biopsy-confirmed myocarditis were reviewed. Right ventricular systolic function was evaluated qualitatively and quantitatively by descent of the right ventricular base. Patients were divided into those with normal right ventricular function, in whom right ventricular descent was 1.9 +/- 0.1 cm, and those with abnormal right ventricular function, in whom right ventricular descent was 0.8 +/- 0.1 cm (p < 0.001). There were no differences between the two groups in age, duration of symptoms, baseline hemodynamics, or histologic assessment. Initial left ventricular ejection fraction was significantly lower in patients with depressed right ventricular function (27.5 +/- 4.9%) compared with that in patients with normal right ventricular function (47.5 +/- 6.3%) (p = 0.01). The likelihood of an adverse outcome, defined as death or need for cardiac transplantation, was greater in patients with abnormal right ventricular function (right ventricular descent less than or equal to 1.7 cm) than in patients with normal right ventricular function (right ventricular descent > 1.7 cm) (p < 0.03). Multivariate analysis revealed that right ventricular dysfunction as quantified by right ventricular descent was the most powerful predictor of adverse outcome.
引用
收藏
页码:301 / 307
页数:7
相关论文
共 28 条
[1]   CURRENT CONCEPTS - MYOCARDITIS [J].
ABELMANN, WH .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 275 (15) :832-&
[2]  
Aretz H T, 1987, Am J Cardiovasc Pathol, V1, P3
[3]   GIANT-CELL VERSUS LYMPHOCYTIC MYOCARDITIS - A COMPARISON OF THEIR CLINICAL-FEATURES AND LONG-TERM OUTCOMES [J].
DAVIDOFF, R ;
PALACIOS, I ;
SOUTHERN, J ;
FALLON, JT ;
NEWELL, J ;
DEC, GW .
CIRCULATION, 1991, 83 (03) :953-961
[4]   ACTIVE MYOCARDITIS IN THE SPECTRUM OF ACUTE DILATED CARDIOMYOPATHIES - CLINICAL-FEATURES, HISTOLOGIC CORRELATES, AND CLINICAL OUTCOME [J].
DEC, GW ;
PALACIOS, IF ;
FALLON, JT ;
ARETZ, HT ;
MILLS, J ;
LEE, DCS ;
JOHNSON, RA .
NEW ENGLAND JOURNAL OF MEDICINE, 1985, 312 (14) :885-890
[5]  
DEC GW, 1988, BRIT HEART J, V60, P32
[6]   DIAGNOSIS AND CLASSIFICATION OF MYOCARDITIS BY ENDOMYOCARDIAL BIOPSY [J].
FENOGLIO, JJ ;
URSELL, PC ;
KELLOGG, CF ;
DRUSIN, RE ;
WEISS, MB .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (01) :12-18
[7]  
GARDINER AJ, 1973, BRIT HEART J, V35, P433
[8]  
Goldberger J J, 1991, J Am Soc Echocardiogr, V4, P140
[9]  
GREENBAUM RA, 1981, BRIT HEART J, V45, P248
[10]  
HOSENPUD JD, 1986, BRIT HEART J, V56, P55